Triple negative breast cancer (TNBC), is a particularly aggressive subtype of breast cancer which is Oestrogen Receptor negative (ER), Progesterone Receptor negative (PR) and does not overexpress the Human Epidermal Growth Factor Receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.